Dyne Therapeutics Inc (DYN)

11:10 AM

Dyne Therapeutics to Announce Topline Results from Phase 1/2 DELIVER Trial of Zeleciment Rostudirsen on December 8, 2025 - Quiver Quantitative

11:10 AM

11:00 AM

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:0 - GlobeNewswire

11:00 AM

Dec 05, 2025

Saturn V Capital Management LP Purchases Shares of 1,455,429 Dyne Therapeutics, Inc. $DYN - MarketBeat

Dec 05, 2025

Dec 04, 2025

Will Dyne Therapeutics Inc. stock benefit from automationStock Surge & Risk Adjusted Buy/Sell Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? - AOL.com

Dec 03, 2025

Dec 03, 2025

JPMorgan Chase & Co. Has $29.39 Million Stock Holdings in Dyne Therapeutics, Inc. $DYN - MarketBeat

Dec 03, 2025

Dec 02, 2025

DYN: Late-stage neuromuscular programs show strong efficacy, with U.S. launches planned for 2027–2028 - TradingView

Dec 02, 2025

Dec 02, 2025

DYN: DMD and DM1 therapies near launch, with strong data and rapid commercialization plans - TradingView

Dec 02, 2025

Dec 01, 2025

Geode Capital Management LLC Has $21.46 Million Stock Position in Dyne Therapeutics, Inc. $DYN - MarketBeat

Dec 01, 2025

Nov 30, 2025

Franklin Resources Inc. Cuts Stock Holdings in Dyne Therapeutics, Inc. $DYN - MarketBeat

Nov 30, 2025

Nov 30, 2025

Bernstein Sees Favorable Risk-Reward for Dyne Therapeutics (DYN) Ahead of Major DYN-251 Data Release - Finviz

Nov 30, 2025

Nov 29, 2025

12 Best Upside Stocks to Buy Now - Insider Monkey

Nov 29, 2025

Nov 28, 2025

Ensign Peak Advisors Inc Has $2.53 Million Position in Dyne Therapeutics, Inc. $DYN - MarketBeat

Nov 28, 2025

Nov 26, 2025

Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger - MSN

Nov 26, 2025

Nov 25, 2025

Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis - MSN

Nov 25, 2025

Nov 25, 2025

Bernstein raises Dyne Therapeutics stock price target to $21 on favorable risk-reward - Investing.com Canada

Nov 25, 2025

Nov 21, 2025

Why Dyne Therapeutics Stock Was Crushing it This Week - The Globe and Mail

Nov 21, 2025

Nov 21, 2025

Will Dyne Therapeutics Inc. stock see PE expansionMarket Sentiment Summary & Verified Technical Trade Signals - newser.com

Nov 21, 2025

Nov 21, 2025

Why Dyne Therapeutics Inc. stock is favored by top institutions - newser.com

Nov 21, 2025

Nov 20, 2025

Can Dyne Therapeutics Inc. stock reach $100 price targetWall Street Watch & Low Drawdown Investment Ideas - newser.com

Nov 20, 2025

Nov 19, 2025

Is Dyne Therapeutics Inc. stock attractive for long term wealth buildingWeekly Trading Summary & AI Optimized Trade Strategies - newser.com

Nov 19, 2025

Nov 19, 2025

Dyne Therapeutics Inc.’s volatility index tracking explained2025 Price Momentum & Low Risk Entry Point Guides - newser.com

Nov 19, 2025

Nov 19, 2025

Will Dyne Therapeutics Inc. stock deliver better than expected guidanceQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Dyne Therapeutics Inc. stock go up soon2025 Market Sentiment & Verified Technical Trade Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Is Dyne Therapeutics Inc. reversing from oversold territoryIPO Watch & Reliable Breakout Forecasts - newser.com

Nov 19, 2025

Nov 19, 2025

Historical volatility pattern of Dyne Therapeutics Inc. visualized2025 Major Catalysts & Capital Protection Trading Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Dyne Therapeutics (NASDAQ:DYN) Trading 9% HigherHere's What Happened - MarketBeat

Nov 18, 2025

Nov 17, 2025

Dyne Therapeutics Inc. stock volume spike explainedInflation Watch & High Return Trade Guides - newser.com

Nov 17, 2025

Nov 16, 2025

Technical Reactions to DYN Trends in Macro Strategies - news.stocktradersdaily.com

Nov 16, 2025